Track the Canadian Junior Mining Market at the speed of AI

Build a portfolio of Canadian junior mining companies on 6ix and get real-time updates the minute they announce something. Discover investor events, company profiles, and news in one place.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
7m ago	Lode Gold Invites Shareholders to Fremont Gold Mine Webinar: 2026 MRE Delivers 1.1 Moz M&I Gold, Path to Value Creation - June 4, 2026, at 12pm Pacific (PST) Lode Gold Resources Inc
8m ago	Phenom Reports Consistent Results on Rare Earth and Critical Metals Deposit at Crescent Valley Phenom Resources Corp
8m ago	Liftoff Announces Launch of Initial Public Offering Life360, Inc.
8m ago	Optimi Health (OPTH) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update Optimi Health Corp.
8m ago	Allied Gold Advances Receipt of Regulatory Approvals and Clearances in Connection with the Proposed Arrangement with Zijin Gold International and Extends the Outside Date to July 29, 2026 Allied Gold Corporation

About

9.69USD-0.50 -4.96%

Closed • Updated at 20:09 GMT+00:00

Market Cap$256.90M

Volume80.3K

Beta1.02

RSI46.63

Health TechnologyPharmaceuticals: Major

Nuvectis Pharma, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting

Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights

Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC

Nuvectis Pharma to Host a Virtual Key Opinion Leader Meeting to Discuss the NXP900 Phase 1b Program in Advanced Solid Tumors, Including the Combination with Osimertinib in NSCLC

Recent Videos

How to Invest in Nuvectis Pharma Inc (NVCT) Step by Step

How to Invest in Nuvectis Pharma Inc (NVCT) Step by Step

Mar 28, 2026

The $4.2B Biotech Pivot: Why Nuvectis (NVCT) is Going "All-In" on NXP900 | 2026 Strategic Audit

The $4.2B Biotech Pivot: Why Nuvectis (NVCT) is Going "All-In" on NXP900 | 2026 Strategic Audit

Feb 17, 2026

Nuvectis Pharma, Inc. (NVCT) #epidermalGrowthFactorReceptorMutated #nonSmallCellLungCancer

Nuvectis Pharma, Inc. (NVCT) #epidermalGrowthFactorReceptorMutated #nonSmallCellLungCancer

Jan 17, 2026

Health News Roundup: Heatwave Heart Risks, Nuvectis Pharma Insider Buying, HeartBeam's ECG System...

Health News Roundup: Heatwave Heart Risks, Nuvectis Pharma Insider Buying, HeartBeam's ECG System...

Jun 20, 2025

Community Chat

Ask AI

Try asking